Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

NCT03960151 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Compound was sold by funder and development ceased.

Conditions

Germ Cell Tumor

Interventions

DRUG: Rolapitant
DRUG: Palonosetron
DRUG: Olanzapine
DRUG: Dexamethasone

Sponsor

Costantine Albany

Collaborators

[object Object]